Commerce Bank Acquires 19,906 Shares of Danaher Corporation (NYSE:DHR)

Commerce Bank raised its position in Danaher Corporation (NYSE:DHR) by 4.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 426,902 shares of the conglomerate’s stock after purchasing an additional 19,906 shares during the period. Commerce Bank owned about 0.06% of Danaher worth $36,620,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. ETRADE Capital Management LLC raised its holdings in shares of Danaher by 5.1% in the 2nd quarter. ETRADE Capital Management LLC now owns 19,075 shares of the conglomerate’s stock worth $1,610,000 after purchasing an additional 917 shares during the period. Honeywell International Inc. acquired a new stake in Danaher during the 2nd quarter valued at approximately $25,317,000. Roundview Capital LLC lifted its holdings in Danaher by 2.0% during the 2nd quarter. Roundview Capital LLC now owns 25,674 shares of the conglomerate’s stock worth $2,167,000 after buying an additional 502 shares during the last quarter. Eastern Bank lifted its holdings in Danaher by 4,291.1% during the 2nd quarter. Eastern Bank now owns 128,001 shares of the conglomerate’s stock worth $10,802,000 after buying an additional 125,086 shares during the last quarter. Finally, Perkins Coie Trust Co lifted its holdings in Danaher by 2.0% during the 2nd quarter. Perkins Coie Trust Co now owns 29,431 shares of the conglomerate’s stock worth $2,484,000 after buying an additional 586 shares during the last quarter. 76.32% of the stock is currently owned by institutional investors.

Danaher Corporation (NYSE:DHR) traded down $0.08 during trading hours on Wednesday, reaching $92.74. The company’s stock had a trading volume of 2,376,900 shares, compared to its average volume of 2,632,848. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. The firm has a market cap of $64,566.07, a P/E ratio of 23.86, a price-to-earnings-growth ratio of 2.21 and a beta of 1.02. Danaher Corporation has a 12-month low of $76.27 and a 12-month high of $94.82.

Danaher (NYSE:DHR) last released its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.05. Danaher had a return on equity of 11.29% and a net margin of 13.36%. The firm had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. During the same quarter in the prior year, the company earned $0.87 EPS. The company’s revenue was up 9.6% on a year-over-year basis. analysts forecast that Danaher Corporation will post 3.99 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be paid a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.60%. Danaher’s dividend payout ratio (DPR) is currently 16.52%.

Several brokerages recently issued reports on DHR. Cowen reissued a “buy” rating and issued a $90.00 price target on shares of Danaher in a report on Wednesday, October 4th. J P Morgan Chase & Co reiterated an “overweight” rating and set a $95.00 price target on shares of Danaher in a research report on Friday, September 8th. Robert W. Baird lifted their price target on Danaher from $87.00 to $97.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a report on Thursday, October 5th. Finally, Goldman Sachs Group reiterated a “neutral” rating and set a $83.00 price target on shares of Danaher in a report on Tuesday, September 26th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $93.31.

In other news, Director Donald J. Ehrlich sold 10,578 shares of Danaher stock in a transaction on Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total transaction of $960,693.96. Following the transaction, the director now owns 104,621 shares in the company, valued at $9,501,679.22. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Daniel L. Comas sold 88,184 shares of the business’s stock in a transaction on Monday, October 23rd. The shares were sold at an average price of $91.02, for a total transaction of $8,026,507.68. Following the completion of the transaction, the chief financial officer now owns 227,816 shares in the company, valued at approximately $20,735,812.32. The disclosure for this sale can be found here. Insiders sold a total of 273,810 shares of company stock valued at $25,218,813 over the last quarter. 12.20% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION NOTICE: “Commerce Bank Acquires 19,906 Shares of Danaher Corporation (NYSE:DHR)” was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://stocknewstimes.com/2017/12/06/commerce-bank-has-36-62-million-stake-in-danaher-corporation-dhr.html.

Danaher Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply